Gene · 5142
Papers1,785
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,785
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Learned Conformational Space and Pharmacophore Into Molecular Foundational Model. | Adv Sci (Weinh) | 2026 | 41486619 | PubTator, text mining | PubMed |
| Nerandomilast as the first PDE4B-selective therapy in idiopathic pulmonary fibrosis. | Trends Pharmacol Sci | 2026 | 41354560 | PubTator, text mining | PubMed |
| Nerandomilast, a PDE4B inhibitor, alleviates silica-induced lung inflammation and fibrosis by inhibition of NLRP3 inflammasome and TGF-β/Smad signalling. | Br J Pharmacol | 2026 | 41255094 | PubTator, text mining | PubMed |
| OSA Initiates Histone Lactylation That Drives PDE4B/FUS/AGT Axis to Pulmonary Hypertension. | Cell Prolif | 2026 | 41243803 | PubTator, text mining | PubMed |
Polyethylene terephthalate microplastics exposure enhances the risk of ulcerative colitis: insights from multiomics integration, machine learning, and molecular docking reveal intestinal toxicity mechanisms. | Int J Surg | 2026 | 40981471 | PubTator, text mining | PubMed |
| Phosphodiesterase 4B (PDE4B) inhibitors and their applications in recent years (2014 to early 2025). | Mol Divers | 2026 | 40515964 | PubTator, text mining | PubMed |
| Genomic and ancestral variations linked to the development of post-acute sequelae of SARS-CoV-2 infection in Indian populations. | Front Genet | 2025 | 41561974 | PubTator, text mining | PubMed |
| Combining Experimental Assays and Molecular Modeling to Evaluate Monosubstituted Cinnamic Acid Derivatives as PDE4B Inhibitors. | ACS Omega | 2025 | 41476481 | PubTator, text mining | PubMed |
| Integrative Transcriptomic and Machine-Learning Analysis Reveals Immune-Inflammatory and Stress-Response Alterations in MRONJ. | Int J Mol Sci | 2025 | 41465220 | PubTator, text mining | PubMed |
| Shared Genetic Architecture and Neurobiological Pathways of Problematic Alcohol Use and Anxiety Disorders. | medRxiv | 2025 | 41358306 | PubTator, text mining | PubMed |
| Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON). | BMC Pulm Med | 2025 | 41345848 | PubTator, text mining | PubMed |
| Mapping the brain cell-specific regulatory architecture of migraine: a single-cell causal framework nominating inhibitory-neuronal BTBD16 and astrocytic RIMS1 as therapeutic targets. | J Headache Pain | 2025 | 41345547 | PubTator, text mining | PubMed |
| Exploring Genetic Markers for Cold-Heat Patterns: Integrating Traditional Medicine With Modern Genomic Research. | Genet Res (Camb) | 2025 | 41322252 | PubTator, text mining | PubMed |
| Design and development of potent roflumilast analogues targeting PDE-4B: selectivity and pharmacokinetic insights. | Bioorg Chem | 2025 | 41205475 | PubTator, text mining | PubMed |
| High glucose promotes cisplatin chemoresistance in MDA-MB-231 breast cancer derived cells through changes in gene expression and multiple signaling pathways. | Biomed Rep | 2025 | 41159042 | PubTator, text mining | PubMed |
| Correction: PDE4B promotes ferroptosis in nucleus pulposus cells and is involved in intervertebral disc degeneration. | Sci Rep | 2025 | 41006568 | PubTator, text mining | PubMed |
| Colorectal Neoplasia Pathogenesis in Normal Appearing Colonic Mucosa -A Perspective With Focus on Eicosanoid Signaling Pathways. | Cancer Med | 2025 | 40980975 | PubTator, text mining | PubMed |
| Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque Psoriasis. | Exp Dermatol | 2025 | 40970551 | PubTator, text mining | PubMed |
| Detecting suicide risk in bipolar disorder patients from lymphoblastoid cell lines genetic signatures. | Transl Psychiatry | 2025 | 40903457 | PubTator, text mining | PubMed |
| Ontogenetic stage and type of donor cells shape extracellular vesicles' therapeutic potential for osteoarthritis. | Stem Cell Res Ther | 2025 | 40890860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5142/papers?page=4